Physicians' Academy for Cardiovascular Education

Higher event risk with DAPT with potent P2Y12-antagonist than with clopidogrel-based treatment

ESC 2017 - Barcelona

3' education - Aug. 29, 2017

Disclosures

Prof.dr. Clemens von Birgelen - Medisch Spectrum Twente, Enschede, The Netherlands